Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia

Clin Microbiol Infect. 2021 Sep;27(9):1360-1361. doi: 10.1016/j.cmi.2021.04.029. Epub 2021 May 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Australia / epidemiology
  • Drug Resistance, Bacterial*
  • Escherichia coli Infections* / drug therapy
  • Escherichia coli Infections* / epidemiology
  • Escherichia coli* / drug effects
  • Escherichia coli* / genetics
  • Fosfomycin* / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Urinary Tract Infections* / drug therapy
  • Urinary Tract Infections* / epidemiology
  • beta-Lactamases

Substances

  • Anti-Bacterial Agents
  • Fosfomycin
  • beta-Lactamases